CONNECT WITH US
HealthTech

HealthTech

Ira Mellman wants Parker Institute to restore cancer immunotherapy

Endpoints News logo

Published on

Add as a preferred source on Google
Ira Mellman wants Parker Institute to restore cancer immunotherapy

Ira Mellman, president of research at the Parker Institute for Cancer Immunotherapy, on Sept. 16, 2026 (Photo by Brian Vanderbrug)

Can­cer is a ‘wily foe,’ and Ira Mell­man fears drug­mak­ers are quit­ting the im­munother­a­py fight ear­ly

While the whole world was ap­plaud­ing Rev­o­lu­tion Med­i­cines’ new can­cer drug, all Ira Mell­man felt was dis­ap­point­ment and frus­tra­tion.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.



Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.